Aspasia Georgala
Overview
Explore the profile of Aspasia Georgala including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
133
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Georgala A, Klastersky J
Curr Opin Oncol
. 2025 Jan;
37(2):163-167.
PMID: 39869037
Purpose Of Review: Febrile neutropenia as a complication of cytotoxic chemotherapies, remains a major event in the medical journey of hematology and oncology patients. In this review, we are trying...
2.
Schalkwijk H, Georgala A, Gillemot S, Temblador A, Topalis D, Wittnebel S, et al.
J Infect Dis
. 2023 May;
228(11):1505-1515.
PMID: 37224525
Background: Herpes simplex virus 1 can cause severe infections in individuals who are immunocompromised. In these patients, emergence of drug resistance mutations causes difficulties in infection management. Methods: Seventeen herpes...
3.
Gourari K, Catherine J, Garaud S, Kerger J, Lepida A, Georgala A, et al.
Diagnostics (Basel)
. 2022 Feb;
12(2).
PMID: 35204627
Tyrosine kinase inhibitors (TKIs) and immune checkpoint inhibitors (ICIs) significantly improve the outcomes of patients with advanced clear cell renal cell carcinoma (ccRCC); however, high-grade toxicities can occur, particularly during...
4.
Mekkaoui L, Hallin M, Mouchet F, Payen M, Maillart E, Clevenbergh P, et al.
PLoS One
. 2021 Apr;
16(4):e0249734.
PMID: 33831077
Among the challenges in controlling tuberculosis, a rapid and accurate diagnostic test for the detection of Mycobacterium tuberculosis complex (MTBc) and its resistance to first line therapies is crucial. We...
5.
Sidibe F, Traore Z, Georgala A, Kanab R, Larsimont D, Awada A, et al.
Bull Cancer
. 2018 Jul;
105(9):842-846.
PMID: 30057027
Endometrial small cell carcinoma (ESCC) is an extremely rare and aggressive tumor with poor prognosis. It is characterized by early regional and systemic spread leading to rapid development of lymph...
6.
Georgala A, Klastersky J
Expert Rev Hematol
. 2014 Nov;
8(1):115-21.
PMID: 25431921
A major advance in the management of febrile neutropenia (FN) has been the stratification of the population of adult patients with FN for the risk of complications and death. Using...
7.
Klastersky J, Georgala A
Crit Rev Oncol Hematol
. 2014 Aug;
92(3):268-78.
PMID: 25151213
Combinations of antibiotics (namely penicillins and aminoglycosides) have been advocated in the 1970s for the empirical therapy of FN in cancer patients in order to take advantage of the possible...
8.
Andrei G, Georgala A, Topalis D, Fiten P, Aoun M, Opdenakker G, et al.
J Infect Dis
. 2013 Jan;
207(8):1295-305.
PMID: 23315323
Background: Infections caused by acyclovir-resistant isolates of herpes simplex virus (HSV) after hematopoietic stem cell transplantation (HSCT) are an emerging concern. An understanding of the evolutionary aspects of HSV infection...
9.
Paesmans M, Klastersky J, Maertens J, Georgala A, Muanza F, Aoun M, et al.
Support Care Cancer
. 2010 Jul;
19(7):1001-8.
PMID: 20596732
Background: Febrile neutropenic cancer patients represent a heterogeneous population with a limited proportion at risk of serious medical complications. The Multinational Association for Supportive Care in Cancer (MASCC) score has...
10.
Klastersky J, Paesmans M, Georgala A, Muanza F, Plehiers B, Dubreucq L, et al.
J Clin Oncol
. 2006 Sep;
24(25):4129-34.
PMID: 16943529
Purpose: Since febrile neutropenic patients were recognized to constitute a heterogeneous population, several models have been developed for predicting the risk of serious medical complications. The Multinational Association for Supportive...